ABSTRACT
Background Scabies is a neglected tropical disease of the skin, causing severe itching, stigmatizing skin lesions and systemic complications. Since 2015, the DerMalawi project provides an integrated skin diseases clinics and Tele-dermatology care in Malawi. Clinic-based data suggested a progressive increase in scabies cases observed. To better identify and treat individuals with scabies in the region, we shifted from a clinic-based model to a community-based outreach programme.
Methods From May 2015, DerMalawi project provide integrated skin diseases and Tele-dermatological care in the Nkhotakota and Salima health districts in Malawi. Demographic and clinical data of all patients personally attended are recorded. Due to a progressive increase in the number of cases of scabies the project shifted to a community-based outreach programme.
For the community outreach activities, we conducted three visits between 2018 to 2019 and undertook screening in schools and villages of Alinafe Hospital catchment area. Treatment was offered for all the cases and school or household contacts.
Results Scabies increased from 2.9% to 39.2% of all cases seen by the DerMalawi project at clinics between 2015 to 2018. During the community-based activities approximately 50% of the population was assessed in each of three visits. The prevalence of scabies was similar in the first two rounds, 15.4% (2392) at the first visit and 17.2% at the second visit. The prevalence of scabies appeared to be lower (2.4%) at the third visit. The prevalence of impetigo appeared unchanged and was 6.7% at the first visit and 5.2% at the final visit.
Conclusions Prevalence of scabies in our study setting was very high suggesting that scabies is a major public health problem in parts of Malawi. Further work is required to more accurately assess the burden of disease and develop appropriate public health strategies for its control.
PLAIN ENGLISH SUMMARY Scabies is an infestation of the skin caused by a mite. There is limited data on how common scabies is in sub-Saharan Africa, including Malawi. The DerMalawi project has been providing care for dermatological conditions in rural Malawi since 2015. Between 2015 and 2018 we observed an increase in patients with scabies attending for treatment. In response, the project shifted from providing care at clinics to an approach using community-based outreach.
Between 2018 and 2019 we conducted community-based activities on three occasions in an area of approximately 30,000 individuals. The DerMalawi team visited schools and villages to identify and treat cases of scabies and their contacts. We were able to examine about 50% of the population on each visit.
Initially a large proportion of the population had scabies (15%) and this was similar during our second community survey. At our third survey this appeared to have decreased to 2% but it is difficult for us to know if this is because of treatment given in the previous rounds.
Scabies is a major problem in rural populations in Malawi and public health strategies are needed to reduce the disease burden.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This work is not a Clinical Trial. Data reported were routinely collected as part of the activities of the DerMalawi project. The DerMalawi project was established in May 2015 to provide free, integrated skin diseases care and Tele-dermatological consultations to communities in the Nkhotakota and Salima health districts in Malawi. The DerMalawi project is governed by a memorandum of understanding between a group of Spanish dermatologists and the Malawian Health authorities with approval for all activities in the district granted by the Nkhotakota health authorities. Patients give verbal consent when attending the DerMalawi project for an assessment of their skin problems. Approval from the Malawi Medical Council and District Hospital for the DerMalawi project are available in supporting information.
Funding Statement
This work was supported by donations from individuals, companies (CantabriaLabs https://www.cantabrialabs.es/ , Martiderm https://www.martiderm.es/ ,Pierre Fabre https://www.pierre-fabre.com/es-es and Italfarmaco https://www.italfarmaco.es/), Ayuntamiento de Villanueva de la Canada https://www.ayto-villacanada.es/ , and students from Secondary School Las Encinas, from Villanueva de la Canada, Madrid (Spain) https://www.ieslasencinas.es/ , Celia Delgado Matias Association http://www.asociacionceliadelgadomatias.org/ http://www.asociacionceliadelgadomatias.org/proyectos/2018-2/ , University of Salamanca https://www.usal.es/ , the collaboration agreement between the Spanish Academy of Dermatology (AEDV) and the The State Foundation, Health, Childhood and Social Welfare, P.S.F. of the Spanish Ministry of Health (former Spanish Foundation for International Cooperation, Health and Social Policy). https://contrataciondelestado.es/wps/poc?uri=deeplink%3AperfilContratante&idBp=4lhzg%2BRWZr4%3D, the international Cooperation Awards from the Spanish Academy of Dermatology (AEDV) https://aedv.es/ ; https://fundacionpielsana.es/dermatologia-solidaria/la-solidaridad-de-los-dermatologos-tiene-premio , the Colegio Oficial de Medicos de Madrid (ICOMEM) https://www.icomem.es/ https://www.icomem.es/comunicacion/noticias/3343/El-Colegio-de-Medicos-de-Madrid-incrementa-el-numero-de-proyectos-y-la-cuantia-economica-dedicada-a-proyectos-de-cooperacion-internacional-en-salud , the Fundacion Mutua Madrilena (FMM) https://www.fundacionmutua.es/ ; https://www.fundacionmutua.es/FundMM/action/main?execution=e1s1 , and the International Cooperation Award from the Central section of the Spanish Academy of Dermatology (SC-AEDV) https://seccion-centro.aedv.es/ https://seccion-centro.aedv.es/dermatologia-solidaria/ ; All donations were delivered through Zikomo Africa Organization http://www.zikomoafrica.org/ and Emalaikat Foundation https://fundacionemalaikat.es/
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data reported were routinely collected as part of the activities of the DerMalawi project. The DerMalawi project was established in May 2015 to provide free, integrated skin diseases care and Tele-dermatological consultations to communities in the Nkhotakota and Salima health districts in Malawi. The DerMalawi project is governed by a memorandum of understanding between a group of Spanish dermatologists and the Malawian Health authorities with approval for all activities in the district granted by the Nkhotakota health authorities. Patients give verbal consent when attending the DerMalawi project for an assessment of their skin problems. Approval from the Malawi Medical Council and District Hospital for the DerMalawi project are available in supporting information.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are fully available without restriction. All relevant data are within the manuscript and its Supporting Information files.
